IgM-enriched immunoglobulin treatment significantly improves coagulation dysbalance in an experimental animal model of fulminant sepsis

Key Points

• Improved coagulation dysbalance is observed with IgM-enriched immunoglobulin treatment in sepsis.
• The treatment resulted in significant improvements, with a notable reduction in coagulation abnormalities.
• Experimental model assessments reveal beneficial effects on hemostatic parameters and infectious complications.
• Potential implications for using IgM-enriched immunoglobulin as a treatment in severe sepsis cases.